Position in LYEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$365,045
-$273,143 QoQ
Shares Held
25,982
-18.3% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 87 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. LYEL ranks #310 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in LYEL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $365,045 | 25,982 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $638,188 | 31,814 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $406,388 | 13,203 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $344,969 | 21,242 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $226,604 | 25,634 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $59,395 | 110,401 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $553,143 | 864,287 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $150,023 | 108,713 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $122,978 | 84,813 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $444,166 | 199,178 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $424,549 | 218,840 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $286,761 | 195,076 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $487,106 | 153,178 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $522,227 | 221,283 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,426,259 | 411,026 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $148,930 | 20,318 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $34,021 | 5,218 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $25,250 | 5,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $111,517 | 14,408 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,966 | 268 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||